News Releases

Product-related press releases will be removed from our website within three weeks after publication. Press releases are made available for the media and to comply with applicable rules and regulations they are removed from our website. Previous press releases can be provided upon request. Please contact us here.

October 2, 2023
Ascendis Presents TransCon™ PTH Data at the American Thyroid Association Annual Meeting
September 23, 2023
Ascendis Pharma Presents Results from Long-Term enliGHten Trial of TransCon™ hGH in Pediatric Growth Hormone Deficiency
September 15, 2023
Ascendis Pharma Launches SKYTROFA® (lonapegsomatropin) in Germany for the Once-Weekly Treatment of Children and Adolescents with Growth Hormone Deficiency
Displaying 1 - 10 of 35